Couldn't agree more with your analysis of the alert that
Couldn't agree more with your analysis of the alert that you received, filings and coming events along with EGOC continuing to check off "carefully" all of the boxes and moving forward. It is going to be a wonderful year I can see it coming. Even though the over all market right now is a bit anemic I see EGOC/ECEN making some big moves. A lot of us figured around March and April being the big mega jump in PPS although it may come sooner than that. I get the feeling based upon some new faces showing up on the "other board" along with all of the ducks lining up in a row concerning name and ticker change etc... Like you pointed out a couple of days ago there are at least 2 people that posted on IHUB that have 4000 plus and 3000 plus followers. That is huge. Geez how does one get that many followers anyway? lol
I had a guy over there on IHUB PM me saying what I thought were kind of strange comments concerning a possible run up in the works because of those huge followings and kind of tried to link me to some sort of planned action he thought might be in the works lol.. or at least he or she seemed to suggest that.. kind of a cryptic PM ( a few of them on that topic) I guess asking me if I was friends with one of those guys with a big lol at the end was suggesting that I was part of something..I just shrugged it off as I guess I was more insulted by him saying that he didn't believe that I am old and didn't believe that I golf daily.. I pointed out to him that I usually get 4 rounds of golf a week under my belt on average.. The golf thing was what kind of urked me a bit lol. As for the rest of his cryptic messages I just found his observations strange and perhaps a bit interesting.
But all things considered there have been some new old faces showing up over there recently along with not so pleasant posters so I think we may be seeing a build up happening.. A lot of new faces *or at least posters that rarely if ever post on ihub EGOC board....
I guess When there is a gold mine that is about to explode and shower the neighborhood with gold nuggets it doesn't take long for the word to get out some times. Nobody knows for sure when the run up happens but I am reasonably sure it will happen! and probably in the coming days/weeks maybe a month or two... Have a great weekend everybody and we can do some EGOC share bargain hunting Monday morning! Cheers.
2
Energy 1 Corporation (EGOC) Stock Research Links
What I post is my opinions and thoughts based on my research. Please do your own DD before buying or selling any stock. I am just as capable as the next guy in making good or bad investment choices! We win a few, we lose a few. That is the nature of the game!
Scroll down for more posts ▼
Top 10 Most Recent News Articles
BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...
Continue Reading
Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....
Continue Reading
Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...
Continue Reading
Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...
Continue Reading
What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...
Continue Reading
New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...
Continue Reading
Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...
Continue Reading
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...
Continue Reading
Top 5 Most Recently Viewed Articles
Viatris Launches Cash Tender Offers for Outstanding Notes Viatris Inc. (NASDAQ: VTRS), a leading player in the global healthcare sector, has initiated tender offers to acquire certain outstanding notes. This move is designed to strengthen its financial framework and enhance returns for its shareholders. Notably, the offers include various senior notes that were originally...
Continue Reading
Coke Florida Kicks Off Holiday Spirit with Caravan Tour Coca-Cola Beverages Florida, LLC (Coke Florida) is thrilled to share that its beloved annual "Holiday Caravan" is set to return. This event, which has become an essential part of the holiday season, features the iconic Coca-Cola red delivery truck decked out in festive cheer. Families will enjoy complimentary samples...
Continue Reading
Nexxen's Upcoming Participation at RBC Global Conference Nexxen International Ltd. (AIM/NASDAQ: NEXN), a leading global advertising technology platform, is geared up to take part in a significant event, the RBC Global Technology, Internet, Media and Telecommunications Conference. This event provides a stellar opportunity for companies to connect with investors and share...
Continue Reading
GayVeterans.us Achieves 501(c)(3) Tax Exempt Status GayVeteransUS-Inc. has recently been granted 501(c)(3) tax-exempt status, marking a significant milestone for the organization. This designation enables supporters to make tax-deductible contributions, strengthening the community's ability to provide enhanced resources and support. The dedication of veteran volunteers...
Continue Reading
Virbac Enhances Its Offerings with Felanorm Acquisition Virbac has announced a significant acquisition that marks a pivotal moment in its commitment to improving the health and quality of life for senior cats. This globally recognized drug is aimed at treating feline hyperthyroidism, a condition that is becoming increasingly common in older cats. Understanding Feline...
Continue Reading